News about Market

Indian API, CRAMS sectors to outperform other countries during 2021-26: research report

Indian API, CRAMS sectors to outperform other countries during 2021-26: research report

The Indian active pharmaceutical ingredients (API) sector is expected to outperform other countries with an estimated Compound Annual Growth Rate (CAGR) of 9.6 per cent over the calendar year 2021-26, while complex APIs would see a faster growth owing to the focus on complex formulations and others

Market | 13/09/2021 | By Darshana

Deal value in pharma industry decreases by 67.2 per cent in August: Globalata

Deal value in pharma industry decreases by 67.2 per cent in August: Globalata

The latest GlobalData report has revealed that the pharmaceutical industry reported 56 deals worth $11.7 billion last month as compared to the last 12-month average (August 2020 to July 2021) of 104 deals worth $28.9 billion

Market | 08/09/2021 | By Darshana

RIL arm acquires stake in Strand Life Sciences

RIL arm acquires stake in Strand Life Sciences

Reliance Strategic Business Ventures Limited, a wholly owned subsidiary of Reliance Industries Limited has acquired stake in Strand Life Sciences for a cash consideration of Rs. 393 crore

Market | 04/09/2021 | By Darshana

Pfizer to acquire Trillium Therapeutics

Pfizer to acquire Trillium Therapeutics

Pfizer and Trillium Therapeutics yesterday announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium, a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer. Under the terms of the agreement

Market | 24/08/2021 | By Darshana

NPPA caps trade margin of 42 anti-cancer medicines, MRP of 562 brands gets reduced up to 90%

NPPA caps trade margin of 42 anti-cancer medicines, MRP of 562 brands gets reduced up to 90%

The National Pharmaceutical Pricing Authority (NPPA) has put a cap on trade margin of 42 select non-scheduled anti-cancer medicines under the ?Trade Margin Rationalization (TMR)?

Market | 11/08/2021 | By Darshana

DCGI classifies 51 medical devices related to respiratory health under rules

DCGI classifies 51 medical devices related to respiratory health under rules

The Drugs Controller General (India) has classified 51 medical devices pertaining to respiratory treatments under the provisions of Medical Devices Rules, 2017, the rule formed to regulate them with respect to the import, manufacture, sale and distribution, and clinical investigation

Market | 10/08/2021 | By Darshana

Sanofi to acquire clinical-stage mRNA therapeutics company, Translate Bio for US$ 3.2 billion

Sanofi to acquire clinical-stage mRNA therapeutics company, Translate Bio for US$ 3.2 billion

As part of Sanofi?s endeavor to accelerate the application of messenger RNA (mRNA) to develop therapeutics and vaccines, the company has entered into a definitive agreement with Translate Bio, a clinical-stage mRNA therapeutics company

Market | 04/08/2021 | By Darshana

Oximeters, BP machines and 3 other devices to get cheaper as trade margins capped at 70%

Oximeters, BP machines and 3 other devices to get cheaper as trade margins capped at 70%

The National Pharmaceutical Pricing Authority has capped trade margins at 70 percent for pulse oximeter, blood pressure monitoring machine, nebulizer, digital thermometer and glucometer. The revised prices come into effect from July 20<br />

Market | 14/07/2021 | By Darshana

Redcliffe Lifetech introduces mucormycosis multiplex RT-PCR test to detect DNA of Mucorales species

Redcliffe Lifetech introduces mucormycosis multiplex RT-PCR test to detect DNA of Mucorales species

Redcliffe Lifetech, a leading molecular diagnostics company, has introduced a non-invasive (serum/fluid) RT-PCR test to detect the DNA of Mucorales species. As a part of the diagnostic process, BAL samples will be used to directly detect the infection, with sample-to-result collection in less than 24 hours

Market | 03/06/2021 | By Darshana

UK MHRA approves one-dose Janssen Covid-19 vaccine

UK MHRA approves one-dose Janssen Covid-19 vaccine

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted regulatory approval for the Janssen?s Covid-19 vaccine. This is the fourth Covid-19 vaccine to be authorised by the UK?s independent regulator and is the first to be approved for protection against Covid-19 with a single dose

Market | 31/05/2021 | By Darshana

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology